Genetic basis of immune-mediated diseases

 

While an enormous number of genetic variants have been associated with risk for human disease, how these variants affect gene expression in various cell types remains largely unknown. To address this gap as it relates to immune cells, as well as to identify which immune cell types are most susceptible to the effects of disease-risk variants, the DICE (Database of Immune Cell Expression, Expression quantitative trait loci (eQTLs) and Epigenomics) project was established in 2014, led by my laboratory (https://dice-database.org/)

 

Selected References

  1. Chandra V, Bhattacharyya S, Schmiedel BJ, Madrigal A, Fotsing S, Seumois G, Kronenberg M, Peters B, and Ay F, and Vijayanand P (2020). Promoter-Interacting Expression Quantitative Trait Loci (pieQTLs) in Human Immune Cell Types. Nature Genetics (in press)
  2. Schmiedel BJ, Chandra V, Rocha J, Gonzalez-Colin C, Bhattacharyya S, Madrigal A, Ottensmeier CH, Ay F, Vijayanand P. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types. bioRxiv [Preprint]. 2020 Dec 2:2020.12.01.407429. doi: 10.1101/2020.12.01.407429. PMID: 33299987; PMCID: PMC7724655.
  3. Benjamin J. Schmiedel, D. S., Ariel Madrigal, Alan G. Valdovino-Gonzalez, Brandie M. White, Jose Zapardiel-Gonzalo, Brendan Ha, Gokmen Altay, Jason A. Greenbaum, Graham McVicker, Grégory Seumois, Anjana Rao, Mitchell Kronenberg, Bjoern Peters, Vijayanand P(2018). Impact of genetic polymorphisms on human immune cell gene expression. 2018 Nov 29 (175), 1701–1715. PMID: 30449622; PMCID: PMC6289654.
  4. Schmiedel BJ, Seumois G, Samaniego-Castruita D, Cayford J, Schulten V, Chavez L, Ay F, Sette A, Peters B, Vijayanand P. (2016). 17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells.Nature Communications. 7:13426. PMCID: PMC5116091.
  5. Seumois G, Chavez L, Gerasimova A, Lienhard M, Omran N, Kalinke L, Vedanayagam M, Ganesan AP, Chawla A, Djukanović R, Ansel KM, Peters B, Rao A, Vijayanand P. (2014). Epigenomic analysis of primary human T cells reveals novel enhancers associated with Th2 memory differentiation and asthma susceptibility. Nature Immunology. 15(8):777-88. PMCID: PMC4140783

 

Grants

NIH/NIAID R24AI108564, Research resources: epigenomic and transcriptomic profiles of human immune cells.

About La Jolla Institute

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.

Share this Article:

LJI Professor Sujan Shresta, Ph.D., is a leader in dengue virus research and vaccine development
LJI and Synbal, Inc. scientists develop new tool for pandemic preparedness